Literature DB >> 7830016

Cancer incidence: life table risk versus cumulative risk.

L J Schouten1, H Straatman, L A Kiemeney, A L Verbeek.   

Abstract

STUDY
OBJECTIVE: To study differences between various methods of estimating cancer risk in individuals.
DESIGN: Information was obtained from a cancer registry. Lifetime risk was calculated using the life table method, taking competing causes of death into account and using well recognised methods such as the cumulative rate and risk.
SETTING: Regional cancer registry of the Comprehensive Cancer Centre IKL, located in Maastricht, The Netherlands. PATIENTS: Patients with a first primary malignancy in 1989-90 in the catchment area of the cancer registry. MAIN
RESULTS: The lifetime risk of developing cancer was estimated to be 34.8% for males and 30.4% for females. In males, especially, the risk estimates were considerably higher when the cumulative risk was used.
CONCLUSIONS: The life table method is convenient for estimating the probability that a person will develop cancer during a defined period or during his or her lifetime. The other estimates overestimate the risk of the disease under investigation, especially in the very elderly.

Entities:  

Mesh:

Year:  1994        PMID: 7830016      PMCID: PMC1060039          DOI: 10.1136/jech.48.6.596

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  18 in total

1.  Cumulative diagnostic radiation exposure in children with ventriculoperitoneal shunts.

Authors:  Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2008-04       Impact factor: 1.475

2.  Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota.

Authors:  D C Hesdorffer; G Logroscino; E K T Benn; N Katri; G Cascino; W A Hauser
Journal:  Neurology       Date:  2011-01-04       Impact factor: 9.910

3.  Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.

Authors:  Mei-Chuan Hung; Donatus U Ekwueme; Sun Hee Rim; Arica White
Journal:  Cancer Epidemiol       Date:  2016-10-25       Impact factor: 2.984

4.  Lifetime risk and age-of-onset of mental disorders in the Belgian general population.

Authors:  Anke Bonnewyn; Ronny Bruffaerts; Gemma Vilagut; Josué Almansa; Koen Demyttenaere
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-30       Impact factor: 4.328

5.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

6.  Key concepts for estimating the burden of surgical conditions and the unmet need for surgical care.

Authors:  Stephen Bickler; Doruk Ozgediz; Richard Gosselin; Thomas Weiser; David Spiegel; Renee Hsia; Peter Dunbar; Kelly McQueen; Dean Jamison
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

7.  The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromsø, Norway.

Authors:  Luai A Ahmed; Henrik Schirmer; Ashild Bjørnerem; Nina Emaus; Lone Jørgensen; Jan Størmer; Ragnar M Joakimsen
Journal:  Eur J Epidemiol       Date:  2009-05-30       Impact factor: 8.082

8.  Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.

Authors:  Mintsje de Boer; Flora E van Leeuwen; Michael Hauptmann; Lucy I H Overbeek; Jan Paul de Boer; Nathalie J Hijmering; Arthur Sernee; Caroline A H Klazen; Marc B I Lobbes; René R W J van der Hulst; Hinne A Rakhorst; Daphne de Jong
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

9.  Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study.

Authors:  Jane A Driver; Luc Djoussé; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  BMJ       Date:  2008-12-09

10.  Age Conditional Probability of Ocular and Ocular Adnexal Malignancies.

Authors:  Mathias Nittmann; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.